Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
carbidopa and levodopa
Medication labelWhy this: Advisory · dailymed-prescription
Carbidopa and levodopa extended-release tablets are indicated in the treatment of the symptoms of idiopathic Parkinson’s disease (paralysis agitans), postencephalitic parkinsonism, and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication and/or manganese intoxication.
- generic_name
- carbidopa and levodopa
- brand_name
- Carbidopa, Levodopa
- product_names
- Carbidopa and Levodopa, Carbidopa, Levodopa
- ndc
- 58177-383, 58177-383-19, 58177-383-09, 58177-383-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en